Cargando…
Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017
Vaccination has been a successful strategy in influenza prevention. However, despite the safety and efficacy of the vaccines, they can cause adverse events following immunization (AEFI). Moreover, due to the vaccination success, most of vaccine-preventable diseases (VPD) have become rare, and public...
Autores principales: | Gattás, Vera Lúcia, Braga, Patrícia Emília, Koike, Marcelo Eiji, Lucchesi, Maria Beatriz Bastos, de Oliveira, Mayra Martho Moura, Piorelli, Roberta de Oliveira, Queiroz, Vivian, Precioso, Alexander Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300789/ https://www.ncbi.nlm.nih.gov/pubmed/30570077 http://dx.doi.org/10.1590/S1678-9946201961004 |
Ejemplares similares
-
Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups
por: Vanni, Tazio, et al.
Publicado: (2021) -
Prospective cohort studies to evaluate the safety and immunogenicity
of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto
Butantan
por: Mondini, Gabriella, et al.
Publicado: (2018) -
Economical Value of Vaccines for the Developing Countries—The Case of Instituto Butantan, a Public Institution in Brazil
por: Ho, Paulo Lee, et al.
Publicado: (2011) -
The Butantan Institute: History and Future Perspectives
por: De Franco, Marcelo, et al.
Publicado: (2014) -
Celebrating 120 Years of Butantan Institute Contributions for Toxinology
por: Moura-da-Silva, Ana M.
Publicado: (2022)